₹ 6.2 Cr
Volume Transacted
(Nov 22, 2024)
246.9 K
Stocks Traded
(Nov 22, 2024)
Last Updated on: Nov 23, 2024
Piramal Pharma Ltd
NSE: PPLPHARMA
ISIN
INE0DK501011
Last updated on: Nov 23, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Piramal Pharma Ltd
NSE: PPLPHARMA
Share Price
₹ 249.9
3.95 (1.61%)
Last updated on: Nov 22, 2024
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
22 Nov 2024 | 249.9 | 246.75 | 253.3 | 245.2 |
21 Nov 2024 | 245.95 | 250.65 | 253.95 | 245 |
19 Nov 2024 | 250.8 | 256 | 259.9 | 248.25 |
18 Nov 2024 | 251.95 | 262.75 | 262.75 | 244.3 |
14 Nov 2024 | 258.4 | 264.45 | 267.1 | 254.45 |
13 Nov 2024 | 259.7 | 249.55 | 277 | 244.75 |
12 Nov 2024 | 250.55 | 267.1 | 269.45 | 248.95 |
11 Nov 2024 | 269.65 | 281.1 | 282.75 | 268.6 |
08 Nov 2024 | 281.8 | 293.1 | 293.55 | 279.25 |
07 Nov 2024 | 292.1 | 295.45 | 303 | 289.35 |
Date | Price (₹) |
---|---|
22 Nov 2024 | 249.9 |
21 Nov 2024 | 245.95 |
19 Nov 2024 | 250.8 |
18 Nov 2024 | 251.95 |
14 Nov 2024 | 258.4 |
13 Nov 2024 | 259.7 |
12 Nov 2024 | 250.55 |
11 Nov 2024 | 269.65 |
08 Nov 2024 | 281.8 |
07 Nov 2024 | 292.1 |
Company Name | ISIN Code |
---|
Cipla Ltd | INE059A01026 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Mankind Pharma Ltd | INE634S01028 |
Company Name | ISIN Code |
---|---|
Cipla Ltd | INE059A01026 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Mankind Pharma Ltd | INE634S01028 |
Last updated time: 23 Nov 15:30 PM
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Piramal Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Piramal Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Piramal Pharma hits life high on reporting multi-fold jump in Q2 PAT
Revenue from operations grew by 17.28% year on year (YoY) to Rs 2,241.75 crore during the ...
24 Oct 202412:32
Piramal Pharma to declare Quarterly Result
Piramal Pharma will hold a meeting of the Board of Directors of the Company on 23 October ...
15 Oct 202410:20
Piramal Pharma to invest $80M to expand its Lexington, Kentucky facility
Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Or...
30 Sep 202418:48
Piramal Pharma receives SBTi validation for its GHG commitment
Piramal Pharma has embarked on its sustainability journey as the Science Based Targets ini...
17 Sep 202410:14
Piramal Pharma grants 48.30 lakh stock options
Piramal Pharma has granted 48,30,836 stock options under Employee Stock Option and Incenti...
26 Jul 202410:05
Piramal Pharma Q1 net loss narrows to Rs 89 crore
Revenue from operations grew by 11.57% year on year (YoY) to Rs 1,951.14 crore during the ...
26 Jul 202414:28
Unlimited trading at just
Rs. 199*